A gynecologist reviewed the timing of hormone replacement therapy, treatment for irregular periods, and management of genitourinary symptoms at a recent conference.
Although polycystic ovary syndrome is a mystery to much of medicine, emerging data about neuroendocrine involvement in the condition shed light for further research.
The FIGO HyPO-P system for the classification of ovulatory disorders is submitted for consideration as a worldwide standard, according to the writing committee.